Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Rating of "Buy" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have received an average recommendation of “Buy” from the five brokerages that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have issued a report on the […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 5,830,000 shares, a drop of 9.9% from the February 29th total of 6,470,000 shares. Approximately 5.8% of the company’s shares are sold short. Based on an […]
StockNews.com upgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday. A number of other brokerages have also recently commented on CPRX. Oppenheimer initiated coverage on shares of Catalyst Pharmaceuticals in a research note on Thursday, December 21st. They […]
Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have received an average recommendation of “Buy” from the four research firms that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued ratings on the stock […]